Cellectar Biosciences, Inc. (CLRB)
3.99
+0.07
(+1.79%)
USD |
NASDAQ |
Dec 10, 16:00
4.00
+0.01
(+0.25%)
After-Hours: 20:00
Cellectar Biosciences Total Liabilities (Quarterly): 5.248M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Imunon, Inc. | 4.906M |
| PDS Biotechnology Corp. | 25.25M |
| PAVmed, Inc. | 12.28M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.63M |
| Shareholders Equity (Quarterly) | 9.379M |
| Debt to Equity Ratio | 0.046 |
| Current Ratio | 2.773 |
| Net Debt Paydown Yield | 0.20% |